Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children (Q24245474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

title

Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

author name string

J White

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

T J Lasserson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

A B Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

E H Steele

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

publication date

19 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

CD005309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Rapid effect of inhaled steroids on nocturnal worsening of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Systemic effect comparisons of six inhaled corticosteroid preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Adrenal function and high dose inhaled corticosteroids for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Budesonide for chronic asthma in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Fluticasone at different doses for chronic asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

True device compliance: the need to consider both competence and contrivance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Beclomethasone for asthma in children: effects on linear growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

Inhaled beclomethasone versus placebo for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

7 January 2021

Inhaled fluticasone versus placebo for chronic asthma in adults and children

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

7 January 2021

Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005309.PUB2

7 January 2021

10.1002/14651858.CD005309.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16235400 AND SRC:MED&resulttype=core&format=json

8 January 2020

1 reference